Brain Hemorrhage Monitoring Made Possible

Working to deliver a non-invasive brain scanner that can monitor the neurological status of a patient at any given time.

Contact Us

Meeting the challenges of real-time brain monitoring

1 in 5 people who suffer strokes or severe traumatic brain injury each year die due to worsening conditions, delayed treatment, and lack of continuous brain monitoring.

Medical personnel has to rely on an amalgam of information – clinical exams, vital signs, implanted ICP monitors – to get an idea of whether the brain is bleeding in between CT/MRI scans.

Sense acts as an adjunct to CT/MRI and can detect active bleeding in the brain and alert medical personnel about worsening brain conditions.

The technology driving our product

The Sense device transmits a low power tailored electro-magnetic (EM) pulse in the RF range across the patient’s brain, and detects changes in the signal that may indicate acute bleeding, brain swelling, or blocked blood vessels.

Sense collects 720 data points every 40 seconds, 18 data points/second and facilitates on-going monitoring of neurological conditions.

Sense has the potential to revolutionize patient care and to change the game when it comes to real-time, continuous brain monitoring.

Experienced leadership team

Sense Diagnostics is a clinical-stage medical technology company developing innovative products to address the need to detect, diagnose and monitor brain injuries and strokes. Our company seeks to become a global leader in neurological diagnostics through innovation and technology and by providing a product that may reduce health care costs and save millions of lives.

We aim to aid medical personnel and support them in their effort to detect and monitor brain conditions in real-time.

Geoff Klass

Geoff Klass

CEO

Serial Entrepreneur, Experienced Executive, Deep MedTech Network

Joe Korfhagen, PhD

Joe Korfhagen, PhD

Director, R&D

Neuroscience PhD, 8 years on technology

Dan Kincaid, JD

Dan Kincaid, JD

COO

Serial Entrepreneur, Managed Care Executive, Angel Investor

Ope Adeoye, MD

Ope Adeoye, MD

CMO

Emergency Medicine/Neurocritical Care, Clinical Trial Leader, Medical School Faculty

George Shaw, MD, PhD

George Shaw, MD, PhD

CTO

Emergency Medicine, Physicist, Medical School Faculty

Matt Flaherty, MD

Matt Flaherty, MD

CCO

Neurology, Clinical Trial Leader, Medical School Faculty

Join Us

Our team works diligently to make our innovative brain scanner a reality for patients.

We are driven by our mission and are committed to impacting people’s lives and enhancing neurological health globally.

Copyright Sense Neuro 2019 All Rights Reserved. Designed by Node.

Brain Hemorrhage Monitoring Made Possible

Working to deliver a non-invasive brain scanner that can monitor the neurological status of a patient at any given time.

Contact Us

Meeting the challenges of real-time brain monitoring

1 in 6 people who suffer strokes or severe traumatic brain injury each year die due to worsening conditions, delayed treatment, and lack of continuous brain monitoring.

Medical personnel has to rely on an amalgam of information – clinical exams, vital signs, implanted ICP monitors – to get an idea of whether the brain is bleeding in between CT/MRI scans.

Sense acts as an adjunct to CT/MRI and can detect active bleeding in the brain and alert medical personnel about worsening brain conditions.

The technology driving our product

The Sense device transmits a low power tailored electro-magnetic (EM) pulse in the RF range across the patient’s brain, and detects changes in the signal that may indicate acute bleeding, brain swelling, or blocked blood vessels.

Sense collects 720 data points every 40 seconds, 18 data points/second and facilitates on-going monitoring of neurological conditions.

Sense has the potential to revolutionize patient care and to change the game when it comes to real-time, continuous brain monitoring.

Experienced leadership team

Sense Diagnostics is a clinical-stage medical technology company developing innovative products to address the need to detect, diagnose and monitor brain injuries and strokes. Our company seeks to become a global leader in neurological diagnostics through innovation and technology and by providing a product that may reduce health care costs and save millions of lives.

We aim to aid medical personnel and support them in their effort to detect and monitor brain conditions in real-time.

Geoff Klass

Geoff Klass

CEO

Serial Entrepreneur, Experienced Executive, Deep MedTech Network

Joe Korfhagen, PhD

Joe Korfhagen, PhD

Director, R&D

Neuroscience PhD, 8 years on technology

Dan Kincaid, JD

Dan Kincaid, JD

COO

Serial Entrepreneur, Managed Care Executive, Angel Investor

Ope Adeoye, MD

Ope Adeoye, MD

CMO

Emergency Medicine/Neurocritical Care, Clinical Trial Leader, Medical School Faculty

George Shaw, MD, PhD

George Shaw, MD, PhD

CTO

Emergency Medicine, Physicist, Medical School Faculty

Matt Flaherty, MD

Matt Flaherty, MD

CCO

Neurology, Clinical Trial Leader, Medical School Faculty

Join Us

Our team works diligently to make our innovative brain scanner a reality for patients.

We are driven by our mission and are committed to impacting people’s lives and enhancing neurological health globally.

Contact Us!

2 + 9 =

We’re social:

info@senseneuro.com
1776 Mentor Ave. Suite 411
Cincinnati, OH 45212

Copyright Sense Neuro 2019 All Rights Reserved. Designed by Node.